Pricing Log in Create free account
Friday 6 November 2026 Export GRDN’s income statement to Excel — free account

Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Guardian Pharmacy Services, Inc. (GRDN) EBITDA

Alert me on EBITDA

Guardian Pharmacy Services, Inc.'s EBITDA for fiscal 2025 was $95.0M, compared with −$43.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $117.6M. Guardian Pharmacy Services, Inc. ranks 28th of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $95.0M —
FY2024 −$43.1M —
FY2023 $59.2M —

Quarterly newest first

Period EBITDA Change
Sep 2026 $31.0M 17.17%
Jun 2026 $26.5M 11.84%
Mar 2026 $23.7M (35.21%)
Dec 2025 $36.5M 64.49%
8 more quarters

EBITDA against peers

Company EBITDA
SGRY Surgery Partners, Inc. compare $583.3M
ACHC Acadia Healthcare Company, Inc. compare $539.9M
BKD Brookdale Senior Living Inc. compare $436.2M
AVAH Aveanna Healthcare Holdings Inc. compare $307.9M
MD Pediatrix Medical Group, Inc. compare $236.8M
NHC National HealthCare Corporation compare $190.4M
ADUS Addus HomeCare Corporation compare $172.9M
ASTH Astrana Health, Inc. compare $168.1M
GRDN Guardian Pharmacy Services, Inc. $117.6M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on GRDN